Archer Investment Corp purchased a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 5,100 shares of the conglomerate's stock, valued at approximately $3,672,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Fox Hill Wealth Management bought a new stake in shares of Danaher in the 2nd quarter valued at about $2,225,000. Kingsview Wealth Management LLC bought a new position in shares of Danaher during the second quarter worth about $2,222,000. Beacon Pointe Advisors LLC bought a new position in shares of Danaher during the second quarter worth about $3,229,000. Pin Oak Investment Advisors Inc. acquired a new position in shares of Danaher in the second quarter worth approximately $174,000. Finally, Ratan Capital Management LP bought a new stake in Danaher in the second quarter valued at approximately $1,067,000. 79.05% of the stock is currently owned by institutional investors.
Danaher Trading Up 0.3%
Shares of DHR opened at $216.41 on Friday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a market cap of $152.13 billion, a PE ratio of 38.44, a P/E/G ratio of 2.69 and a beta of 0.78. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The business's 50-day moving average price is $199.46 and its 200-day moving average price is $192.52.
Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher's revenue was up 5.5% compared to the same quarter last year. During the same period last year, the business earned $0.77 earnings per share. On average, equities analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on DHR. Piper Sandler assumed coverage on Danaher in a report on Thursday, June 11th. They issued a "neutral" rating and a $200.00 target price for the company. HSBC lowered their target price on shares of Danaher from $270.00 to $230.00 and set a "buy" rating on the stock in a report on Wednesday, June 3rd. Citigroup started coverage on shares of Danaher in a research report on Tuesday, May 26th. They issued a "buy" rating and a $230.00 price target on the stock. Royal Bank Of Canada boosted their price objective on Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a report on Wednesday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and an average price target of $228.91.
View Our Latest Research Report on DHR
About Danaher
(
Free Report)
Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.